The potential of 12/15-lipoxygenase inhibitors in stroke therapy. [PDF]
van Leyen K, Holman TR, Maloney DJ.
europepmc +1 more source
5-Lipoxygenase inhibitors isolated from Gardeniae Fructus.
M, Nishizawa +4 more
openaire +3 more sources
A Multistep Computational Approach to Achieve a Complete Human 5-Lipoxygenase Structure and Provide a Pharmacophore Model for Further Drug Design. [PDF]
Lombardo L +3 more
europepmc +1 more source
Allosteric properties of mammalian ALOX15 orthologs. [PDF]
Yang J, Borchert A, Kuhn H.
europepmc +1 more source
Recent Advances in Dual COX/LOX Inhibitor Design (2020-2024): Establishing "The Rule of Four for Inflammation". [PDF]
Chatzipieris FP +4 more
europepmc +1 more source
Structural and computational supported development of 2,5-disubstituted-1,3,4-oxadiazole analogues as active LOX, urease, and α-glucosidase inhibitors. [PDF]
Javid J +11 more
europepmc +1 more source
Development of novel salicylic acid derivatives with dual anti-inflammatory and anti-arthritic potentials: synthesis, <i>in vitro</i> bio-evaluation, and <i>in silico</i> toxicity prediction with molecular modeling simulations. [PDF]
Hesham K, Aboulthana WM, Ragab A.
europepmc +1 more source
Epigenome Modifying Tools In Asthma [PDF]
Adcock,, Brook, PO, Durham, AL, Perry, M
core +1 more source
Developing the risk prediction model (ProlncSig) from lipoxygenase pathway-related lncRNAs for prognosis prediction in breast cancer. [PDF]
Fu X, Wang W, Downs BM, Li J.
europepmc +1 more source
Clicked cinnamic/caffeic esters and amides as radical scavengers and 5-lipoxygenase inhibitors. [PDF]
Doiron JA +9 more
europepmc +1 more source

